Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative Transcriptome Profiling Reveals SKA3 as a Novel Prognostic Marker in Non-Muscle Invasive Bladder Cancer

17 Sept 2021

Abstract excerpt

Approximately 80% of all new bladder cancer patients are diagnosed with non-muscle invasive bladder cancer (NMIBC). However, approximately 15% of them progress to muscle-invasive bladder cancer (MIBC), for which prognosis is poor. The current study aimed to improve diagnostic accuracy associated with clinical outcomes in NMIBC patients. Nevertheless, it has been challenging to identify molecular biomarkers that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34572901
DOI: 10.3390/cancers13184673

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative Transcriptome Profiling Reveals SKA3 as a Novel Prognostic Marker in Non-Muscle Invasive Bladder CancerPMID 34572901Read ↗

Identification of muscle-invasive related genes in bladder cancer single-cell sequencing data for constructing patient prognostic modelSemantic proximity Read ↗

scRNA-seq reveals epithelial heterogeneity in bladder cancer and establishes a cancer stem cell prognostic modelSemantic proximity Read ↗

Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic modelSemantic proximity Read ↗

Integrating Multi-dimensional RNA Sequencing to Construct a Prognostic Risk Model for Bladder CancerSemantic proximity Read ↗

Collaborating single-cell and bulk RNA sequencing for comprehensive characterization of the intratumor heterogeneity and prognostic model development for bladder cancerSemantic proximity Read ↗

Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomesSemantic proximity Read ↗

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Semantic proximity Read ↗

High ORAI3 expression correlates with good prognosis in human muscle-invasive bladder cancer.Semantic proximity Read ↗

Integrated analysis of single-cell and bulk RNA sequencing predicts prognosis and therapeutic response using malignant epithelial cells marker genes in bladder cancerSemantic proximity Read ↗

An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancerSemantic proximity Read ↗

Pan-cancer analysis and verification revealed the clinical significance of SLC9A3R1 in bladder cancer cohortSemantic proximity Read ↗

Single-cell Analysis Highlights Anti-apoptotic Subpopulation Promoting Malignant Progression and Predicting Prognosis in Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.